Osteoarthritis (OA, degenerative joint disease) is the most common form of arthritis. It occurs almost universally in the aged, and results in significant disability in over 20% of patients. Although the etiology of OA is unknown, studies suggest etiologic roles for biochemical, chemical, inflammatory and immunologic factors. It has become increasingly evident that interplays of synovium, cartilage and bone contribute in significant fashion to primary and augmenting pathophysiologic processes. This proposal is designed to 1) use monoclonal antibodies to separately identify serum antigen or antibody markers which reflect cartilage (proteoglycans, glycosaminoglycans, type II collagen), or bone (type I collagen; bone derived CSA, cartilage-stimulating activity factor) so as to noninvasively study cartilage/bone changes in osteoarthritic, normal and aging joints in experimental models and in humans; 2) investigate sequential tissue changes in cartilage lesions in experimental OA using monoclonal antibodies which recognize specific epitopes on rabbit cartilage proteoglycans; and 3) determine the role of immune factors in augmentation of degradative and (secondary) inflammatory changes observed in experimental OA. The relationship of immunoglobulin deposition to evolving pathologic changes will be studied, and reactive antigenic determinants defined. Immunochemical responses of cartilage components to biomechanical, hormonal and biochemical manipulations will be investigated. Studies will provide insights in osteoarthritis pathophysiology and allow for advances in disease definition and diagnosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR030134-10
Application #
3155756
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1981-12-01
Project End
1991-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
10
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Mehraban, F; Tindal, M H; Proffitt, M M et al. (1997) Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Ann Rheum Dis 56:108-15
Denko, C W; Boja, B; Moskowitz, R W (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthritis Cartilage 4:245-9
Pokharna, H K; Monnier, V; Boja, B et al. (1995) Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage. J Orthop Res 13:13-21
Denko, C W; Boja, B; Moskowitz, R W (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725-30
Mehraban, F; Kuo, S Y; Riera, H et al. (1994) Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum 37:1189-97
Moskowitz, R W; Reese, J H; Young, R G et al. (1991) The effects of Rumalon, a glycosaminoglycan peptide complex, in a partial meniscectomy model of osteoarthritis in rabbits. J Rheumatol 18:205-9
Moskowitz, R W; Boja, B; Denko, C W (1991) The role of growth factors in degenerative joint disorders. J Rheumatol Suppl 27:147-8
Denko, C W; Boja, B; Moskowitz, R W (1990) Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 17:1217-21
Mehraban, F; Moskowitz, R W (1989) Serum keratan sulfate levels in rabbits with experimentally induced osteoarthritis. Arthritis Rheum 32:1293-9